Covid-19 Pandemic
 Here’s the latest news: Scientists question study linking hydroxychloroquine to risks Declining infection rates may hinder Covid-19 vaccine trialsAir traffic seen taking three years to recover from virus A victory with few lessons This past week, Japan lifted the state of emergency declaration over the coronavirus. It seemed like a big win for a nation that had all the ingredients for a potentially disastrous situation: proximity to and close ties with China, lack of widespread testing, the world’s oldest population and dense metropolitan areas. Yet the state of emergency was lifted in less than 2 months. At the end of it, Japan had around 16,000 cases and fewer than 1,000 deaths—by far the lowest out of the G7 countries.  Japan inched toward resuming more activities Tuesday after a dropoff in virus cases led the government to end its nationwide state of emergency. Photographer: Kiyoshi Ota/Bloomberg Discussing how Japan beat the virus despite avoiding the usual playbook of strict lockdowns or mass testing has become a national pastime. We delved into the possible factors that helped—a local community health system of nurses also trained in contact-tracing, a population that was already healthy with low obesity rates—in a story that was Bloomberg News’s most-read story globally this week. The tremendous response from readers reflected how polarizing discussions around the idea of “successful” virus containment policies have become. Some nitpicked the details and wording in our story, or said that the data couldn’t be relied on. Others lamented the lack of similar policies and outcomes in their own countries. Lockdowns have been so economically and socially punishing that people seem desperate for other potential solutions. Just as with the global trend of toilet paper being snatched off shelves, people are seeking for any bit of comfort—and feel disappointed when there are no clear answers. But the pandemic is revealing that nothing is black and white and it’s the same thing here, even if Japan seems to have successfully contained its first wave. There’s no one answer to how it succeeded, and no clarity on whether the same set of factors will work again when the second wave comes.—Lisa Du Listen up Latest Podcast: A New Vaccine Frontrunner Riley Griffin talks with Merck CEO Kenneth C. Frazier about the drug giant’s push to produce a vaccine. Once quiet on its development plans, Merck is is now moving to the forefront.  Save the date: How are investors and regulators navigating the current financial landscape, and what’s ahead for global markets? Hear from SEC Chairman Jay Clayton and top asset managers Jenny Johnson of Franklin Templeton and David Hunt of PGIM on June 2nd in the latest of our virtual series, Bloomberg Invest Talks. Get more details and register here. What you should read The Day the Music Stopped in Seattle Will independent music venues survive the pandemic? New York’s Must-Have Accessory: a Mask New Yorkers must accept a new reality, Governor Cuomo says. Gym Junkies Are Rushing Back But casual exercisers have been slower to return as health clubs re-open. A Guide to Post-Lockdown Haircuts Months of confinement have left many around the world desperate. Life Returns to London’s Finance Hub Temperature checks are in, spontaneous coffee meetings are out. Know someone else who would like this newsletter? Have them sign up here. Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story. Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close. Follow Us Get the newsletter You received this message because you are subscribed to Bloomberg’s Coronavirus Daily newsletter. Unsubscribe | Bloomberg.com | Contact Us Bloomberg L.P. 731 Lexington, New York, NY, 10022 |
PreviousHighway Funding